Hyderabad: Wockhardt Ltd is recalling 109,744 bottles of anti-hypertensive drug belonging to multiple lots from the American market following failure of dissolution test, US regulator FDA said. According to a notification by the USFDA, the recall is voluntarily and was initiated by the company from April 1 under ‘Class-II’ classification. The recall of metoprolol is a generic version of AstraZeneca Plc’s branded drug Toprol.
Wockhardt recalls hypertension drug in US
RECENT STORIES
India Electronics Association Lauds Government's Commitment Of ₹4,500 Crore To Modernise...
RBI's Monetary Policy Review To Take Place Amidst Low Inflation & Growth
'Indian Tea Needs To Develop A Wider Catalogue Of Internationally Marketable Varieties': Piyush...
'Under The Leadership Of Prime Minister Narendra Modi, India Is Rapidly Moving Toward Self-Reliance...
SEBI Chairman Tuhin Kanta Pandey Stresses Need For Financial Literacy & Investor Protection